Pre Market Gaps NYSE & Nasdaq

Gapping up: ZRAN +12.8%, ICO +11.0%, FOE +10.9%, VLTR +10.1%, BMTI +9.0%, BSX +4.7%, MHS +4.6%, MICC +4.4%, WGOV +4.0%, LOGI +3.7%, NBR +3.4%, CE +3.2%, TTEK +2.9%, IFX +2.2%, VE +2.2%, ALB +2.2%, STLD +1.8%, ARTC +1.3%, DD +1.0%, LMT +1.0%...

Gapping down: OMCL -23.4%, CIT -13.7%, NFLX -13.3%, QI -13.2%, BRKR -11.7%, BJS -9.5%, UNH -8.1%, PKG -8.0%, NVLS -5.0%, VNUS -4.5%, ALO -4.4%, CNI -4.3%, RBS -3.9%, CME -3.3%, GENZ -2.8%, TXN -2.3%, ING -2.2%, USNA -1.6%, DB -1.5%, OMG -1.2%, CPO -1.2%.

Gapping up in reaction to strong earnings/guidance: VLTR +12.1% (also upgraded to Outperform at Piper), ZRAN +11.2%, FOE +10.9%, WGOV +8.7%, CPO +6.4%, EAT +6.0%, JBLU +5.5%, BSX +5.1%, KCI +4.8%, MICC +4.4%, BTU +3.8%, LOGI +3.7%, NBR +3.4%, CE +3.2%, ALB +2.2%, LXK +2.0%, STLD +1.8%, T +1.6%, ARTC +1.3%, CR +1.2%, DD +1.0%, LMT +1.0%, HSC +1.0%...

Other news: BMTI +10.1% (receives written communication from FDA confirming status of ongoing pivotal trial for GEM OS1), ICO +9.8% (still checking), FTEK +6.4% (Cramer makes positive comments on MadMoney), MHS +4.6% (Medco Health Solutions, UnitedHealth Group announce pharmacy services agreement; also upgraded to Buy at Jefferies and upgraded to Buy at Citigroup), TTEK +2.9% (Cramer makes positive comments on MadMoney), IFX +2.2% (prepares for disposal and deconsolidation of Qimonda; will record a write-down of euro 1 billion; FY08 EBIT guidance remains unchanged), VE +2.2% (still checking), AGU +1.4% (profiled in New America section of IBD)...

Analyst upgrades: BRLC +13.2% (upgraded to Outperform at Baird), NCC +4.0% (upgraded to Buy at Deutsche Bank and upgraded to Outperform from Market Perform at Bernstein), BCSI +2.2% (upgraded to Buy at Stifel Nicolaus), LOCM +1.9% (initiated with a Buy at Morgan Joseph).